Skip to content

Prostate Cancer in Firemen: Early Diagnosis Because of Increased Diagnostic Pressure?

Early Detection of Prostate Cancer in Firefighters - a Register-based Study of Prognostic Factors and Survival

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03896178
Enrollment
137536
Registered
2019-03-29
Start date
2020-02-01
Completion date
2020-02-02
Last updated
2021-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Brief summary

Firefighters, police, military personnel and pilots are all shown to have a higher incidence of prostate cancer than the general population. A possible explanation for this is that these four groups of employees need regular mandatory health-checkups. If these checkups increase the chances of having a PSA or DRE performed one could expect the workers in question to have a higher probability than the general population of being diagnosed with prostate cancer. If this is the case the four groups should have cancers that are lower grade and have better survival. The investigators wish to examine this by comparing the four groups with a control group made up of all other workers with regards to prognostic factors at the time of diagnosis and survival rates. This will be done by extracting data from the Cancer Registry of Norway, coupled with employment data from Statistics Norway. This study is also a part of a project on cancer in firefighters. If the prostate cancers in firefighters differ significantly from the other three specified groups, this could point to an exposure specific for firefighters, e.g. fire smoke, as an etiologic factor.

Interventions

None, observational study

Sponsors

Norwegian Institute of Public Health
CollaboratorOTHER_GOV
Extrastiftelsen
CollaboratorOTHER
The National Institute of Occupational Health
CollaboratorUNKNOWN
Norwegian Confederation of Trade Unions
CollaboratorUNKNOWN
Fagforbundet
CollaboratorUNKNOWN
Gjensidige Foundation
CollaboratorUNKNOWN
Norwegian Cancer Society
CollaboratorOTHER
Norwegian Firefighters Fight Cancer
CollaboratorUNKNOWN
Norwegian Labour Inspection Authority
CollaboratorUNKNOWN
Oslo University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
OTHER

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All cases of prostate cancer as registered by the Cancer Registry of Norway

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frame
Cause-specific mortality rate for prostate cancerFrom January 1st 1960 until December 31st 2018

Secondary

MeasureTime frameDescription
TNM stagingJanuary 1st 1960 until December 31st 2018
Gleason scoreJanuary 1st 1960 until December 31st 2018Score based on microscopic appearance of prostate cancer tissue. Sum of two scores, each ranging from 1-5 (only whole numbers), meaning the final score ranges from 2-10. A higher score is associated with a more aggressive/less differentiated tumor. It is normal to group scores 2-6 together in \>7. It is also normal to differentiate between 7 (4+3) (worse), and 7 (3+4) (better).
PSA at time of diagnosisJanuary 1st 1960 until December 31st 2018
Functional status at time of diagnosis (WHO classification)January 1st 1960 until December 31st 2018

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026